• CN EN

    • CN
    Pipeline
    Developing Products That are
    Potent, Enabling, Novel and Safe
    nrHSC

    Product

    Indication

    Drug
    Discovery

    Pre-clinical

    IND

    Phase I

    Phase II

    Phase III

    BLA

    Commer-cialization

    MVR-Vac11

    MVR-Gen11

    Vaccine

    Gene Delivery

    Technology Edge
    Multifunctional Proteins and Nucleic Acid Delivery


    Breakthrough viral vector modification strategy allowing various administration methods to meet broader clinical scenarios

    Targeted Delivery

    Breakthrough viral vector modification strategy allowing various administration methods to meet broader clinical scenarios

    Streamlined Drug Discovery

    Breakthrough viral vector modification strategy allowing various administration methods to meet broader clinical scenarios

    A company focusing on developing novel
    drug delivery vector technology

    Phone:0512-66202028

    Address:Wuzhong Biology Medical Company Industrial Park Phase 3 Block A2, Guoxiang Street, Wuzhong District, Suzhou, China

    Copyright © 2014-2022 IMMVIRA CO.,LTD All Rights Reserved 粤ICP备17163742号-6